33,868 results on '"diazepam"'
Search Results
2. Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
- Author
-
Alice Chen, M.D., Investigator
- Published
- 2024
3. Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers
- Published
- 2024
4. A longitudinal MRI and TSPO PET-based investigation of brain region-specific neuroprotection by diazepam versus midazolam following organophosphate-induced seizures
- Author
-
Hobson, Brad A, Rowland, Douglas J, Dou, Yimeng, Saito, Naomi, Harmany, Zachary T, Bruun, Donald A, Harvey, Danielle J, Chaudhari, Abhijit J, Garbow, Joel R, and Lein, Pamela J
- Subjects
Biological Psychology ,Biomedical and Clinical Sciences ,Psychology ,Emerging Infectious Diseases ,Epilepsy ,Brain Disorders ,Neurodegenerative ,Biomedical Imaging ,Infectious Diseases ,Bioengineering ,Biodefense ,Neurosciences ,Neurological ,Rats ,Animals ,Diazepam ,Midazolam ,Isoflurophate ,Organophosphates ,Neuroinflammatory Diseases ,Neuroprotection ,Rats ,Sprague-Dawley ,Brain ,Benzodiazepines ,Status Epilepticus ,Positron-Emission Tomography ,Carrier Proteins ,Magnetic Resonance Imaging ,Brain Injuries ,Atrophy ,Diisopropylfluorophosphate ,In vivo imaging ,Neuroinflammation ,Rat ,Status epilepticus ,Pharmacology and Pharmaceutical Sciences ,Neurology & Neurosurgery ,Pharmacology and pharmaceutical sciences ,Biological psychology - Abstract
Acute poisoning with organophosphorus cholinesterase inhibitors (OPs), such as OP nerve agents and pesticides, can cause life threatening cholinergic crisis and status epilepticus (SE). Survivors often experience significant morbidity, including brain injury, acquired epilepsy, and cognitive deficits. Current medical countermeasures for acute OP poisoning include a benzodiazepine to mitigate seizures. Diazepam was long the benzodiazepine included in autoinjectors used to treat OP-induced seizures, but it is now being replaced in many guidelines by midazolam, which terminates seizures more quickly, particularly when administered intramuscularly. While a direct correlation between seizure duration and the extent of brain injury has been widely reported, there are limited data comparing the neuroprotective efficacy of diazepam versus midazolam following acute OP intoxication. To address this data gap, we used non-invasive imaging techniques to longitudinally quantify neuropathology in a rat model of acute intoxication with the OP diisopropylfluorophosphate (DFP) with and without post-exposure intervention with diazepam or midazolam. Magnetic resonance imaging (MRI) was used to monitor neuropathology and brain atrophy, while positron emission tomography (PET) with a radiotracer targeting translocator protein (TSPO) was utilized to assess neuroinflammation. Animals were scanned at 3, 7, 28, 65, 91, and 168 days post-DFP and imaging metrics were quantitated for the hippocampus, amygdala, piriform cortex, thalamus, cerebral cortex and lateral ventricles. In the DFP-intoxicated rat, neuroinflammation persisted for the duration of the study coincident with progressive atrophy and ongoing tissue remodeling. Benzodiazepines attenuated neuropathology in a region-dependent manner, but neither benzodiazepine was effective in attenuating long-term neuroinflammation as detected by TSPO PET. Diffusion MRI and TSPO PET metrics were highly correlated with seizure severity, and early MRI and PET metrics were positively correlated with long-term brain atrophy. Collectively, these results suggest that anti-seizure therapy alone is insufficient to prevent long-lasting neuroinflammation and tissue remodeling.
- Published
- 2024
5. Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience
- Published
- 2024
6. Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre/post-observational study with a control group.
- Author
-
Le, Tammy, Campbell, Scott, Andraos, Alexa, Ahlmark, Pedro, Hoang, Ha, Isserman, Sean, Goldzweig, Caroline, Mays, Allison, Bradley, Kristin, and Keller, Michelle
- Subjects
Health & safety ,Health Education ,Patients ,Primary Health Care ,THERAPEUTICS ,Humans ,Benzodiazepines ,Control Groups ,Deprescriptions ,Patient Education as Topic ,Diazepam ,Delivery of Health Care ,Pain - Abstract
OBJECTIVES: Long-term benzodiazepine use is common despite known risks. In the original Eliminating Medications Through Patient Ownership of End Results (EMPOWER) Study set in Canada, patient education led to increased rates of benzodiazepine cessation. We aimed to determine the effectiveness of implementing an adapted EMPOWER quality improvement (QI) initiative in a US-based healthcare system. DESIGN: We used a pre-post design with a non-randomised control group. SETTING: A network of primary care clinics. PARTICIPANTS: Patients with ≥60 days supply of benzodiazepines in 6 months and ≥1 risk factor (≥65 years of age, a concurrent high-risk medication prescribed or a diazepam equivalent daily dose ≥10) were eligible. INTERVENTION: In March 2022, we engaged 22 primary care physicians (PCPs), and 308 of their patients were mailed an educational brochure, physician letter and flyer detailing benzodiazepine risks; the control group included 4 PCPs and 291 of their patients. PRIMARY AND SECONDARY MEASURES: The primary measure was benzodiazepine cessation by 9 months. We used logistic regression and a generalised estimating equations approach to control for clustering by PCP, adjusting for demographics, frailty, number of risk factors, and diagnoses of arthritis, depression, diabetes, falls, and pain. RESULTS: Patients in the intervention and control groups were comparable across most covariates; however, a greater proportion of intervention patients had pain-related diagnoses and depression. By 9 months, 26% of intervention patients (81 of 308) had discontinued benzodiazepines, compared with 17% (49 of 291) of control patients. Intervention patients had 1.73 greater odds of benzodiazepine discontinuation compared with controls (95% CI: 1.09, 2.75, p=0.02). The unadjusted number needed to treat was 10.5 (95% CI: 6.30, 34.92) and the absolute risk reduction was 0.095 (95% CI: 0.03 to 0.16). CONCLUSIONS: Results from this non-randomised QI initiative indicate that patient education programmes using the EMPOWER brochures have the potential to promote cessation of benzodiazepines in primary care.
- Published
- 2024
7. Rapid Rescue Treatment with Diazepam Nasal Spray Leads to Faster Seizure Cluster Termination in Epilepsy: An Exploratory Post Hoc Cohort Analysis.
- Author
-
Misra, Sunita, Jarrar, Randa, Stern, John, Becker, Danielle, Carrazana, Enrique, and Rabinowicz, Adrian
- Subjects
Benzodiazepine ,Diazepam ,Early Intervention ,Epilepsy ,Intranasal ,Rescue Therapy ,Seizure Cluster ,Timing ,Urgency - Abstract
INTRODUCTION: Although prompt treatment of status epilepticus is standard of care, the effect of timing of rescue therapy administration for seizure clusters in epilepsy remains unknown. Seizure clusters are a rare but clinically important condition, and benzodiazepines are the cornerstone rescue therapy for seizure clusters in epilepsy. We characterized temporal patterns from a large dataset of treated seizure clusters in the safety study of diazepam nasal spray. METHODS: This post hoc analysis used timing data of treated seizure clusters recorded by care partners and patients in seizure diaries during a 1-year safety study. Data analysis used time from seizure start to administration of diazepam. RESULTS: From 4466 observations, 3225 had data meeting criteria for analysis. Overall, median times from seizure start to dose administration, dose administration to seizure termination, and total seizure duration were 2, 3, and 7 min, respectively. In seizure clusters treated in
- Published
- 2024
8. Effects of Diazepam on RNS Detections
- Author
-
Michael Privitera, Professor Neurology
- Published
- 2024
9. Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care
- Author
-
Martha Sajatovic, Physician, UHMG
- Published
- 2024
10. Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo (Vertigo)
- Author
-
Pr. Semir Nouira, PROFESSOR
- Published
- 2024
11. Diazepam Trial in GAD65 Associated Epilepsy
- Author
-
Kelsey M. Smith, Principal Investigator
- Published
- 2024
12. Nonopioid Analgesia After Rotator Cuff Repair
- Author
-
Vasilios Moutzouros, Senior Staff
- Published
- 2024
13. Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children
- Author
-
Arooj Khan, Assistant Professor Muhammad Kashif
- Published
- 2024
14. Remote Treatment of Alcohol Withdrawal
- Author
-
Ontario Ministry of Health and Long Term Care and Canadian Institutes of Health Research (CIHR)
- Published
- 2024
15. Anxiolytic Efficacy of Indirubin: In Vivo Approach Along with Receptor Binding Profiling and Molecular Interaction with GABAergic Pathways.
- Author
-
Disha, Ishrat Jahan, Hasan, Rubel, Bhuia, Shimul, Ansari, Siddique Akber, Ansari, Irfan Aamer, and Islam, Muhammad Torequl
- Abstract
Anxiety is a natural response to stress, characterized by feelings of worry, fear, or unease. The current research was conducted to investigate the anxiolytic effect of indirubin (IND) in different behavioral paradigms in
Swiss albino mice. To observe the animal's behavioural response to assess anxiolytic activity, different tests were performed, such as the open‐field (square cross, grooming, and rearing), swing, dark‐light, and hole cross tests. The experimental mice were administered IND (5 and 10 mg/kg, p.o.), where diazepam (DZP) and vehicle were used as positive and negative controls, respectively. In addition, a combination treatment (DZP+IND‐10) was provided to the animals to determine the modulatory effect of IND on DZP. Molecular docking approach was also conducted to determine the binding energy of IND with the GABAA receptor (α2 and α3 subunits) and pharmacokinetics were also estimated. The findings revealed that IND dose‐dependently significantly (p <0.05) reduced the animal's movement exerting calming behavior like DZP. IND also demonstrated the highest docking score (−7.7 kcal/mol) against the α3 subunit, while DZP showed a lower docking value (−6.4 kcal/mol) than IND. The ADMET analysis revealed that IND has proper drug‐likeness and pharmacokinetic characteristics. In conclusion, IND exerted anxiolytic effects through GABAergic Pathways. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
16. The efficacy of diazepam administration during embryo transfer: a retrospective multicenter cohort study on reproductive outcomes.
- Author
-
Brandão, Pedro, Rafael, Filipa, Saleh, Mohamed, and Sánchez, Fernando
- Subjects
- *
EMBRYO transfer , *BIRTH rate , *PREMATURE labor , *REPRODUCTIVE health , *DIAZEPAM , *FROZEN human embryos - Abstract
Purpose: This retrospective multicenter cohort study aimed to investigate the impact of diazepam administration during embryo transfer on reproductive outcomes, focusing primarily on the live birth rate. Secondary outcomes included the positive beta-hCG rate, clinical pregnancy rate, miscarriage rate, ectopic pregnancy rate, and preterm birth rate. Methods: Data from 5607 embryo transfers, encompassing 465 cases with diazepam administration, were retrospectively analyzed. The study included single blastocyst transfers from 12 clinics in Portugal and Spain between January 2015 and December 2022. Results: Comparison of reproductive outcomes between patients receiving diazepam and those who did not showed no statistically significant differences. Positive beta-hCG rates (60.8% non-diazepam vs. 60.4% diazepam, p = 0.92, adjusted p = 0.32) and clinical pregnancy rates (45.6% non-diazepam vs. 46.2% diazepam, p = 0.81, adjusted p = 0.11) were comparable. Miscarriage rates (11.0% diazepam vs. 9.3% non-diazepam, p = 0.25, adjusted p = 0.26) and ectopic pregnancy rates (0.9% diazepam vs. 0.1% non-diazepam, p = 0.1, adjusted p = 0.20) were similar. Live birth rates (36.3% non-diazepam vs. 35.3% diazepam, p = 0.69, adjusted p = 0.82) and prematurity rates (0.3% non-diazepam vs. 0% diazepam, p > 0.99, adjusted p = 0.99) also exhibited no statistically significant differences. Conclusions: Based on the results, diazepam administration during embryo transfer did not show a discernible impact on reproductive outcomes, including live birth rates, suggesting its limited effectiveness in enhancing success. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Determination of Lorazepam and Diazepam Using Modified Nanocrystalline Cellulose for Ultrasonic-Assisted Dispersive Solid Phase Microextraction (UA-DSPME) and Gas Chromatography-Mass Spectrometry (GC-MS).
- Author
-
Haji Abdolrasouli, Mehdi, Roostaie, Ali, Abedi, Hamid, and Mohammadiazar, Sirwan
- Subjects
- *
GAS chromatography/Mass spectrometry (GC-MS) , *SOLID phase extraction , *LIQUID-liquid extraction , *DIAZEPAM , *CELLULOSE , *FOURIER transform infrared spectroscopy , *LORAZEPAM - Abstract
A rapid and effective method utilizing ultrasonic assisted-dispersive solid-phase microextraction coupled with gas chromatography/mass spectrometry (GC/MS) was developed for the determination of lorazepam and diazepam in biological and aqueous samples. A modified nanocrystalline cellulose-based sorbent was prepared and applied for the microextraction of the analytes. The extraction efficiency of the sorbents prepared using self-assembled N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, including cellulose nanostructure and modified nanocrystalline cellulose, was compared. The modified cellulose nanostructure was characterized using thermogravimetric analysis (TGA), energy dispersive X-ray (EDX), and Fourier transform infrared spectroscopy (FTIR). Additionally, the study investigated the effects of relevant factors on the extraction/desorption performance, including extraction time, ionic strength, and the type and volume of the desorption solvent. The method achieved limits of detection of 1 ng mL−1 and 3 ng mL−1 and quantification limits of 4 ng mL−1 and 10 ng mL−1 for lorazepam and diazepam, respectively. Furthermore, the developed method demonstrated good repeatability with relative standard deviations of 4% and 6% (n = 5) for the spiked analyte aqueous solutions at 50 ng mL−1. The method also exhibited high linearity (R > 0.9996) in the range from 10 to 1000 ng mL−1. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. A comparative study of anti-anxiety properties of ethanolic and aqueous extracts of Ocimum sanctum in animal models.
- Author
-
S. K., Salma Kamal, L., Kudagi B., Mohan, Pathapati Rama, Chandra, Vurimi Bhopal, Haritha, Manchi, and Nelavala, Anjani Devi
- Subjects
OCIMUM sanctum ,REGULATION of body weight ,MAZE tests ,TRANQUILIZING drugs ,SYNTHETIC drugs - Abstract
Background: Anxiety transcends a natural emotion, evolving into a pathological condition with the potential to trigger cascading cardiovascular and psychiatric disorders. Although conventional allopathic medicine offers treatment options, concerns regarding their side effects and long-term efficacy remain prevalent. Medicinal plants contain natural compounds that may be promising sources of therapeutic drugs. Aims and Objectives: This study aims to compare the anxiolytic potential of ethanolic and aqueous extracts of Ocimum sanctum (OS). The growing appeal of plant-based therapies for anxiety stems from perceived advantages in safety and tolerability compared to synthetic drugs. Materials and Methods: The anxiolytic activity of aqueous and ethanolic extract of OS is evaluated with an elevated plus maze test. A total of 36 Wistar albino rats (150-200 g) were used and randomly divided into six groups of six animals each. The effects of the test drug at different doses, 100 and 200 mg/kg, were compared with the standard anxiolytic drug diazepam at 2 mg/kg body weight and the control group using distilled water at 0.5 mL/kg body weight. Results: The behavioral changes suggested reduced anxiety and openarm exploration in plus-maze indicates reduced anxiety in animals treated with OS extracts. The changes are significantly (P < 0.001) comparable with the standard drug diazepam. Conclusion: The ethanolic extracts of OS are more significant than aqueous extracts for evaluating anti-anxiety activity in a dose-dependent manner. In addition, ethanolic extracts are more likely to contain a wider range of bioactive compounds, which are thought to be responsible for the anti-anxiety effects of OS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Peripheral gating of mechanosensation by glial diazepam binding inhibitor.
- Author
-
Xinmeng Li, Silveira Prudente, Arthur, Prato, Vincenzo, Xianchuan Guo, Han Hao, Jones, Frederick, Figoli, Sofia, Mullen, Pierce, Yujin Wang, Tonello, Raquel, Sang Hoon Lee, Shah, Shihab, Maffei, Benito, Berta, Temugin, Xiaona Du, and Gamper, Nikita
- Subjects
- *
DORSAL root ganglia , *SENSORY neurons , *DIAZEPAM , *GLUTAMATE receptors , *SATELLITE cells , *NEUROGLIA - Abstract
We report that diazepam binding inhibitor (DBI) is a glial messenger mediating crosstalk between satellite glial cells (SGCs) and sensory neurons in the dorsal root ganglion (DRG). DBI is highly expressed in SGCs of mice, rats, and humans, but not in sensory neurons or most other DRG-resident cells. Knockdown of DBI results in a robust mechanical hypersensitivity without major effects on other sensory modalities. In vivo overexpression of DBI in SGCs reduces sensitivity to mechanical stimulation and alleviates mechanical allodynia in neuropathic and inflammatory pain models. We further show that DBI acts as an unconventional agonist and positive allosteric modulator at the neuronal GABAA receptors, particularly strongly affecting those with a high-affinity benzodiazepine binding site. Such receptors are selectively expressed by a subpopulation of mechanosensitive DRG neurons, and these are also more enwrapped with DBI-expressing glia, as compared with other DRG neurons, suggesting a mechanism for a specific effect of DBI on mechanosensation. These findings identified a communication mechanism between peripheral neurons and SGCs. This communication modulates pain signaling and can be targeted therapeutically. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Synthesis and Evaluation of the Neurotropic Activity of New β-Cycloketol Derivatives.
- Author
-
Kocharov, S. L., Panosyan, H. A., Mirzoyan, L. S., Nazaryan, I. M., and Paronikyan, R. G.
- Subjects
- *
NUCLEAR magnetic resonance spectroscopy , *DIAZEPAM , *ANTIDEPRESSANTS , *ALKANES , *CONDENSATION , *MUSCLE relaxants - Abstract
Two types of known and new derivatives of substituted β-cycloketols were synthesized; characterized using IR, PMR, and 13C NMR spectroscopy; and tested for neurotropic activity. Bioscreening of the compounds was performed. A study of the neurotropic properties of the synthesized new β-cycloketol derivatives revealed that some of them exhibited a pronounced anticonvulsant effect as antagonism of corazol. The compounds were superior in anticonvulsant activity to the well-known drug ethosuximide but inferior to diazepam. Like ethosuximide, the studied compounds did not exhibit central muscle relaxant activity at anticonvulsant doses, unlike diazepam. However, they exhibited psychotropic effects, e.g., pronounced anxiolytic, antidepressant, and activating behavior. The results showed that further searching for neurotropic properties in new polyfunctional cycloketol derivatives was advisable. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Effects of chromatographic conditions on retention behaviour of different psychoactive agents in high-performance liquid chromatography: A machine-learning-based approach.
- Author
-
Usman, Abdullahi Garba, Erdağ, Emine, and Işık, Selin
- Subjects
- *
HIGH performance liquid chromatography , *STANDARD deviations , *MATHEMATICAL optimization , *MACHINE learning , *LIQUID chromatography - Abstract
Background and Aims: High-pressure liquid chromatography (HPLC) data on the effects of various chromatographic conditions on the retention behaviour of three different psychotropic drugs; clonazepam, diazepam, and oxazepam) were considered for simulation using a machine learning approach. Methods: For the simulation of selected psychoactive compounds using HPLC, different machine learning techniques were used in this study: adaptive neuro-fuzzy inference system, multilayer perceptron, Hammerstein-Weiner model, and a traditional linear model in the form of stepwise linear regression. Four evaluation criteria were used to assess the effectiveness of the models: coefficient of determination, root mean squared error, mean squared error, and correlation coefficient. Results: The results show that machine learning approaches, especially multilayer perceptions, are more reliable than classical linear models with an average coefficient of determination value of 0.98 in both calibration and validation phases. Conclusion: The performance results also demonstrate that these models can be improved using additional approaches, such as hybrid models, ensemble machine learning, evolving algorithms, and optimisation techniques. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database.
- Author
-
Jyrkkä, Johanna, Paulamäki, Jasmin, Hartikainen, Sirpa, Ahonen, Jouni, Antikainen, Riitta, Jauhonen, Hanna-Mari, Jämsen, Esa, Kössi, Anniina, Laurila, Jouko, Roitto, Hanna-Maria, Söderling, Riikka, Tiihonen, Miia, and Huupponen, Risto
- Subjects
- *
DATABASES , *CONSENSUS (Social sciences) , *MEDICAL prescriptions , *PATIENT safety , *DIAZEPAM , *PRIMARY health care , *INTERNET , *DECISION making in clinical medicine , *FINNS , *NERVOUS system , *SOCIAL support , *IBUPROFEN , *MEDICAL practice , *CARDIOVASCULAR agents , *CARDIOVASCULAR system - Abstract
The Finnish web-based Meds75+ database supports rational, safe and appropriate prescribing to older adults in primary care. This article describes the content and updating process of Meds75+ and demonstrates its applicability in everyday clinical practice. Meds75+ contains a classification (A–D) and recommendation texts for 450–500 drug substances when used in the treatment of older adults aged 75 years or older. The content of Meds75+ is continually updated. Each assessment of a drug substance begins with a structured collection of available information and research evidence. After that, an interdisciplinary expert panel discusses the classification and recommendation using a consensus method. A rolling 3-year updating cycle guarantees that all drug substances are reviewed regularly. Most drug substances are classified as class A (41%) (suitable, e.g. bisoprolol) or as class C (37%) (suitable with specific precautions, e.g. ibuprofen). One-fifth (20%) of the substances are in class D (avoid use, e.g. diazepam). Most commonly, older adults have purchased substances affecting the alimentary tract and metabolism (17%), the nervous system (16%) and the cardiovascular system (15%). In Finland, the proportion of older adults using class D substances (37%) has not changed between the years 2019 and 2022. Meds75+ has potential to support safer and more effective use of medications for older adults, since it offers up-to-date information on drug substances for healthcare professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. The effect of magnesium sulfate on memory and anxiety-like behavior in a rat model: an investigation of its neuronal molecular mechanisms.
- Author
-
Cetin, Ali, Ozdemir, Ercan, Golgeli, Asuman, Taskiran, Ahmet Sevki, Karabulut, Sebahattin, Ergul, Mustafa, Gumus, Erkan, and Durna Dastan, Sevgi
- Subjects
LABORATORY rats ,MAGNESIUM sulfate ,ANXIETY ,FRONTAL lobe ,ANIMAL disease models ,ANXIETY disorders - Abstract
Anxiety is an adaptive response to potentially threatening conditions. Excessive and uncontrolled anxiety responses become nonadaptive and cause anxiety disorders. To better understand the anxiety-modulating effects of Mg sulfate, behavioral test batteries in the assessment of anxiety and learning and memory functions were performed simultaneously over a time period. This study also examines the effects of Mg sulfate compared to diazepam, an anxiolytic drug with amnestic effects on anxiety-like behavior, as well as possible oxidative-nitrosative stress and hippocampal changes in male rats exposed to predator odor. Young adult Sprague-Dawley male rats were used. The rats were assessed using a comprehensive neurobehavioral test battery consisting of novel object recognition, open field, and successive alleys tasks. Anxiety was induced by cat odor, and diazepam and Mg were used as study drugs. Of the frontal cortex and hippocampus, the state of total oxidant and antioxidant and NO levels and histological examination of hippocampal CA1, CA2, CA3, and DG regions were performed. Diazepam- and Mg-treated rats showed an improvement in anxiety-related behavior to predator odors. Furthermore, Mg treatment alleviated some of the increasing oxidative stress in the frontal cortex and hippocampus of rats, while diazepam treatment in particular enhanced hippocampal oxidant and antioxidant activity. In addition, brain NO increase induced by animal odor exposure or diazepam treatment was ameliorated by Mg administration. Overall, our work suggests that Mg had a partial anxiolytic effect on anxiety-like behaviors, although not as much as diazepam, and this effect varied depending on the dose. Mg treatment might counteract increased oxidative stress and elevated NO levels in the brain. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Comparative evaluation of the antianxiety effects of Vitamin C, buspirone, and diazepam in rats.
- Author
-
N., Chandralekha, S., Mangala, Pereira, Nicole, and Udaykumar, Padmaja
- Subjects
VITAMIN C ,FISHER exact test ,BUSPIRONE ,ARIPIPRAZOLE ,DIAZEPAM ,TRANQUILIZING drugs ,RATS - Abstract
Background: Anxiety is one of the common mental disorders. Non-fatal health loss is one of the consequences of anxiety disorders. Oxidative stress may also play a role in anxiety disorders. As an antioxidant, Vitamin C can create stable ascorbate free radicals and lower reactive oxygen species. In addition, Vitamin C can prevent damage caused by free radicals. Oxidative stress can also lead to depression, schizophrenia, and bipolar disorder. Aim and Objectives: The aim and objectives of the study are to compare the antianxiety effects of Vitamin C, buspirone, and diazepam in albino rats using elevated plus maze and hole board apparatus. Materials and Methods: 36 albino rats of either sex were divided into 6 groups of 6 rats each and drugs were administered orally. Group 1 received distilled water 10 ml/kg, Group 2 received Vitamin C 200 mg/kg, Group 3 received buspirone 10 mg/kg, Group 4 received diazepam 1 mg/kg, Group 5 received buspirone 10 mg/kg + Vitamin C 200 mg/kg, and Group 6 received diazepam 1 mg/kg + Vitamin C 200 mg/kg. Antianxiety effects of these drugs were tested after 14 days of drug administration using hole board apparatus and elevated plus maze. The methods used for statistical analysis were mean, standard deviation, confidence interval, median, interquartile range (IQR), frequency and percentage, ANOVA, Kruskal-Wallis test, and Fisher's exact test. Results: On average time spent in open arms by Group 5 was 98.00 sec (IQR: 19.75-138.00) which was higher than other groups, but it was not statistically significant (P = 0.845). The time spent in closed arms in seconds by Group 4 was 245 ± 28.863, which was higher than other groups, but it was not statistically significant (P = 0. 805). On average head dip by Group 5 was 9.83 ± 4.708, which was higher than other groups, but it was not statistically significant (P = 0.141). Conclusion: Group 5 rats that received buspirone and Vitamin C, followed by Group 6 rats that received diazepam and Vitamin C had spent more time and had more entries into the open arms. Furthermore, Groups 5 and 6 animals had a greater number of head dips in the hole board apparatus compared to the behavior of all animals in other groups. Buspirone and diazepam are known anxiolytics. When these drugs were given in combination with Vitamin C, the antianxiety behaviors in rats were more compared to the drugs given alone in the present study but it was not statistically significant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Taxifolin as a novel therapeutic agent for epileptic seizures induced by caffeine-induced oxidative stress in rats.
- Author
-
Yasar, Hasan, Altuner, Durdu, Bulut, Seval, Cicek, Betul, Gursul, Cebrail, Kuzucu, Mehmet, and Suleyman, Halis
- Subjects
OXIDANT status ,OXIDATIVE stress ,SUPEROXIDE dismutase ,FLAVONOIDS ,NEUROLOGICAL disorders - Abstract
Background. Epilepsy is a severe neurological disease that results from excessive and/or synchronized neuronal activity in the brain, and oxidative stress plays a role in its pathogenesis. Taxifolin is a flavonoid that exhibits antioxidant activity. Objectives. To investigate the effects of taxifolin on caffeine-induced epileptic seizures in rats and reveal the role of antioxidant activity in antiepileptic therapy. Materials and methods. Forty rats were divided into 4 groups (n = 6/group): caffeine 300 mg/kg group (CG), taxifolin 50 mg/kg + caffeine 300 mg/kg group (TCG), 2 mg/kg diazepam + 300 mg/kg caffeine group (DCG), and a healthy group (HG). Taxifolin was given to the TCG, and diazepam was given to the DCG orally. One hour later, caffeine was injected intraperitoneally into the CG, TCG and DCG rats. The time between the caffeine injection and the contractions (the latency period) was determined. Animals were euthanized 1 h after caffeine injection, and brain tissues were biochemically examined for oxidants and antioxidants. Results. Taxifolin and diazepam prolonged the latency period to a similar extent (p = 0.549), while taxifolin was more successful in preventing mortality. Taxifolin suppressed the caffeine-induced increase in myeloperoxidase, total oxidant status and oxidative stress index, and decreased total glutathione, superoxide dismutase and total antioxidant status more effectively than diazepam (p < 0.05). Conclusions. We showed the relationship between antioxidant activity and epilepsy treatment, and demonstrated that taxifolin may be useful for treating epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Development of a novel dosing paradigm to model diazepam rescue therapy in preclinical seizure and epilepsy models.
- Author
-
Guignet, Michelle, White, H. Steve, Misra, Sunita N., Carrazana, Enrique, and Rabinowicz, Adrian L.
- Subjects
INTRANASAL medication ,DIAZEPAM ,PEOPLE with epilepsy ,LABORATORY animals ,ANIMAL models in research - Abstract
Diazepam is a cornerstone immediate‐use antiseizure rescue therapy that may extend the duration between seizure clusters in people living with epilepsy. However, our mechanistic understanding of intermittent rescue therapy on disease progression is limited by the lack of suitable preclinical models. Specifically, the pharmacokinetics of diazepam varies widely between humans and laboratory animals. Here, we developed a novel repeat rescue therapy dosing paradigm in rats to maintain prolonged therapeutic concentrations seen in humans. Rats received three diazepam doses separated by 1 h (0.75, 1.5, or 3 mg/kg, intraperitoneal); plasma and brains were collected at 10 min and 1, 3, or 6 h following the last dose. Plasma and brain concentrations followed a dose‐dependent increase with peak concentrations following the repeat 3 mg/kg paradigm (180 ng/mL) being equivalent to plasma levels observed in human studies with diazepam nasal spray. Increased brain‐to‐plasma ratios in this paradigm indicate that diazepam accumulation in the brain may be long‐acting at the site of action. Overall, our repeat diazepam dosing paradigm mimics drug concentrations and accumulation seen in humans, offering a preclinical tool to study the impact of benzodiazepine rescue therapy on seizure‐cluster biology in rodent models of epilepsy. Plain language summary: There is more to learn about how diazepam works in the brains of people who use it only when they have two or more seizures in 24 h (this is called a seizure cluster). Ethical studies in animals can be used to learn more about medicines in the body. In this study, we showed that three doses of diazepam in rats give about the same amount of the drug as one dose for a person. We can now test rats with epilepsy to see how the drug might work in people who take it when needed for seizure clusters. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Evaluation of the Effectiveness of Combined Treatment with Intravaginal Diazepam and Pelvic Floor Rehabilitation in Patients with Vulvodynia by Ultrasound Monitoring of Biometric Parameters of Pelvic Muscles: A Pilot Study.
- Author
-
Merlino, Lucia, Ciminello, Enrico, Volpicelli, Agnese Immacolata, Tillier, Stefano, Pasquali, Marianna Francesca, Dominoni, Mattia, Gardella, Barbara, Senatori, Roberto, Dionisi, Barbara, and Piccioni, Maria Grazia
- Subjects
VULVODYNIA ,PELVIC pain ,HOSPITAL patients ,DIAZEPAM ,SYMPTOMS - Abstract
(1) Background: Vulvodynia is characterized by vulvar pain for at least three months and may have related variables, one of these being pelvic floor hypertonus. The purpose of this study was to compare the therapeutic effectiveness of two weekly sessions of pelvic floor rehabilitation and 5 mg of vaginal diazepam daily vs. pelvic floor rehabilitation alone in individuals with vulvodynia. (2) Methods: A single-center, not-blind, randomized study enrolled 20 vulvodynic patients: A total of 10 were treated with dual therapy (intravaginal diazepam and pelvic floor rehabilitation), and 10 were treated with only pelvic floor rehabilitation. All of them underwent a pelvic floor ultrasound examination and VAS pain and Marinoff scale assessments before the beginning of therapy as well as three and six months later. (3) Results: The elevator plate angle ranged from 8.2 to 9.55 (p = 0.0005), hiatal area diameter ranged from 1.277 to 1.482 (p = 0.0002), levator symphysis distance ranged from 3.88 to 4.098 (p = 0.006), anorectal angle ranged from 121.9 to 125.49 (p = 0.006), Marinoff scale ranged from 2.3 to 1.4 (p = 0.009), and VAS scale ranged from 5.8 to 2.8 (p < 0.001). (4) Conclusions: This pilot study demonstrates that the suggested treatment improves the hypertonicity of the pelvic floor, as measured by ultrasound parameters, correlating with a reduction in symptomatology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Design and evaluation of thiophene incorporated benzothiazepines targeting GABA-A receptor as anticonvulsant
- Author
-
Kumar, Abhishek, Kumar, Pankaj, Chaithanya, P, Suhasini, S, Gupta, Dheeraj Rajesh, and Bhaskar, Vijaya K
- Published
- 2024
- Full Text
- View/download PDF
29. Extracts of Prunella vulgaris Enhanced Pentobarbital-Induced Sleeping Behavior in Mice Potentially via Adenosine A2A Receptor Activity.
- Author
-
Sayson, Leandro Val, Campomayor, Nicole Bon, Ortiz, Darlene Mae, Lee, Hyun Jun, Balataria, Sweetie, Park, Sangsu, Lim, Jeongin, Kang, Heejin, Kim, Hee Jin, and Kim, Mikyung
- Subjects
- *
PHYTOTHERAPY , *BIOLOGICAL models , *CAFFEINE , *PENTOBARBITAL , *RESEARCH funding , *DIAZEPAM , *ADENOSINES , *ROSMARINIC acid , *ELECTROENCEPHALOGRAPHY , *PLANT extracts , *SLEEP duration , *MICE , *ANIMAL behavior , *ANIMAL experimentation , *RAPID eye movement sleep , *BRAIN waves , *SLEEP disorders , *WAKEFULNESS - Abstract
The increasing prevalence of sleep dysregulation cases has prompted the search for effective and safe sleep-enhancing agents. Numerous medications used in the treatment of sleep disorders function by enhancing γ -aminobutyric acid neurotransmitter activity. Unfortunately, these substances may induce significant adverse effects in chronic users, such as dependence and motor behavior impairments. Consequently, there is a growing interest in exploring therapeutic sleep-enhancing agents derived from natural sources, with the anticipation of causing less severe side effects. Prunella vulgaris (PV), a perennial plant indigenous to South Korea, exhibits various pharmacological effects, likely attributed to its chemical composition. Rosmarinic acid, one of its components, has previously demonstrated sleep-potentiating properties, suggesting the potential for PV to exhibit similar pharmacological effects. This study aims to investigate the potential effects of repeated administration of PV extract on the sleep behavior, brainwave activity, sleep–wake cycle, and physiological behavior of mice. Findings indicate that PV extracts exhibit sleep-enhancing effects in mice, characterized by prolonged sleep duration and a reduced onset time of pentobarbital-induced sleep. However, PV extracts only reduced alpha wave powers, with minor alterations in wakefulness and rapid-eye-movement sleep duration. In contrast to diazepam, PV extracts lack adverse effects on locomotor activity, motor coordination, or anxiety in mice. Receptor-binding assay and caffeine treatment support the potential involvement of adenosine A2A receptors in the effects of PV, suggesting distinct mechanisms of action compared to diazepam, despite both exhibiting sleep-altering effects. Overall, our results suggest that PV holds promise as a potential source of sleep-aiding agents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk (BENZOGAP)
- Author
-
Wellcome Trust and The Royal Society
- Published
- 2023
31. Nonopioid Analgesia After Arthroscopic Meniscus Surgery
- Author
-
Charles S Day, Orthopedic Surgeon
- Published
- 2023
32. Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
- Author
-
Gaetano Isola, Principal researcher
- Published
- 2023
33. Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy
- Published
- 2023
34. Effect of intramuscular diazepam infusion on herpes zoster-related pain in older patients: a randomized, double-blind, placebo-controlled trial
- Author
-
Bingjie Ma, Meiling Xu, Lu Yang, Xuehua Huang, Peiliang Wang, Yun Ji, and Ke Ma
- Subjects
Diazepam ,Herpes zoster ,Neuralgia ,Sleep quality ,Psychology ,Anesthesiology ,RD78.3-87.3 - Abstract
Abstract Objectives This study evaluated the effectiveness, psychological effects, and sleep quality using intramuscular diazepam infusion compared with placebo in patients with herpes zoster (HZ)-related pain. Methods The patients were randomized to either the diazepam or control group. The diazepam group received an intramuscular injection of diazepam for 3 consecutive days, while the control group received an intramuscular injection of 0.9% normal saline. The primary outcome was pain relief on posttreatment day 4, as measured using the Visual Analog Scale (VAS). Moreover, anxiety and depression were evaluated using the Generalized Anxiety Disorder-7 (GAD7) and Patient Health Questionnaire-9 (PHQ9), respectively. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Results In total, 78 patients were enrolled in the trial. The mean differences in VAS scores between the two groups were 0.62 (P = 0.049) on posttreatment day 3 and 0.66 (P = 0.037) on posttreatment day 4. The effective rates of pain management in the diazepam group ranged from 10.26 to 66.67%, which were higher than those in the control group on posttreatment days 3 and 4 (P
- Published
- 2024
- Full Text
- View/download PDF
35. A case of severe and prolonged γ‐hydroxybutyrate (GHB) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper.
- Author
-
Gupta, Rachit, Moon, Greta, Bonomo, Yvonne, and Pastor, Adam
- Subjects
- *
BENZODIAZEPINE receptors , *BACLOFEN , *ACETONEMIA , *CONSCIOUS sedation , *BLOOD testing , *TRACHEA intubation - Abstract
Introduction Case Presentation Discussion and Conclusions γ‐hydroxybutyrate (GHB) is a GABA‐B agonist that rapidly produces effects that are likened to both alcohol and MDMA/ecstasy. GHB use can lead to neuroadaptation with a characteristic withdrawal syndrome. There is currently a paucity of data on the progression of GHB withdrawal, however, due to the drug's short half‐life it is generally considered to be typically 5–7 days, although some cases can be severe and complicated by life threatening delirium. Here, we present a case of severe GHB withdrawal, which recurred on multiple occasions over 56 days, despite initial clinical stabilisation on each occasion and toxicological evidence of abstinence from GHB between episodes.A male patient in his 30s presented with agitated delirium on a background of severe GHB use disorder with a 15‐year history of daily high dose GHB use. Following 3 hospital admissions over 8 weeks, all requiring intravenous sedation and tracheal intubation, the patient's withdrawal delirium was successfully treated with a slow benzodiazepine and baclofen wean over a period of 6 months. Relapse to GHB use between hospitalisations was excluded toxicologically via blood analysis performed at an institute of forensic pathology.This case highlights that GHB withdrawal can be more prolonged than previously reported in the literature and in some cases may require slow and prolonged tapering of treatment to prevent re‐emergence of delirium. Similar to previous case reports, benzodiazepines and GABA‐B receptor agonists appear to be appropriate drug classes to manage GHB withdrawal. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Effect of nose twitching on the pupillary dilation in awake and anesthetized horses.
- Author
-
Mascaró Triedo, Carlota Emilia, Karar, Sahra, Abunemeh, Maha, and Portier, Karine
- Subjects
NOSE ,HORSES ,PUPILLOMETRY ,DIAZEPAM - Abstract
Pupillometry is used in humans to monitor pain, nociception and analgesia. This single-center, non-randomized, non-blinded intervention trial, evaluated the effect of nose twitching on the pupil size in awake, sedated, and anesthetized horses. Pupil height (H) and length (L) were measured before (Be) and after (Af) nose twitching in fourteen non-painful adult awake horses (T0). The percentage of variation (PSV) was calculated (PSVTn=[(TnAf-TnBe)/TnBe]*100). Measurements were repeated (Tn) after acepromazine (0.04mgkg-1 IV) (T1), romifidine (0.04mgkg-1 IV) (T2), morphine (0.1mgkg-1 IV) (T3), after anesthesia induction with diazepam (0.05mgkg-1 IV) and ketamine (2.2mgkg-1 IV), at the time the horse was placed on the operating table (T4) and when the expiratory fraction of sevoflurane was 2% (T5). HAf vs. HBe, LAf vs. LBe as well as PSVH vs. PSVL at each time were compared with a Mann-Whitney Wilcoxon test. The PSVL and PSVH, as well as HBe and LBe over time were compared with the Skillings-Mack test followed by a Wilcoxon test for paired data to make pairwise comparisons (Tn+ 1 vs. Tn). In non-sedated horses (T0), the application of the nose twitch induced a significant increase in pupil length (LT0Be: 17.09 [16.05; 19.67] mm versus LT0Af: 19.52 [18.74; 21.40]) mm (p = 0.004). Thirty minutes after acepromazine administration (T1), nose twitching induced a significant increase in pupil length (LT1Be: 16.45 [14.80; 18.66] mm versus LT1Af 18.31 [17.20; 20.52] mm) (p = 0.016) and height (HT1Be: 8.44 [5.68; 12.04] mm versus HT1Af: 11.09 [7.97; 14.3] mm) (p < 0.001). PSVHT1 was significantly greater than PSVLT1 (p = 0.025). PSVH was higher at T1 than at T0 (p = 0.04). It was also significantly higher at T1 than at T2 (p < 0.001). Romifidine induced mydriasis (HT2Be 16.95 [14.73; 18.77] mm versus HT1Be 8.44 [5.68; 12.04] mm) (p < 0,001) (LT2Be 19.66 [18.45; 20.41] mm versus LT1Be 16.45 [14.80; 18.66] mm) (p < 0.001). The results suggest that nose twitching induced a pupillary dilation in the awake horse. This effect was potentiated after the administration of acepromazine but disappeared after the administration of romifidine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Expanding the Understanding of Stiff-Person Syndrome: Insights from 17 Cases in India.
- Author
-
Jain, Rajendra S., Pemawat, Ashish, Sharma, Pankajkumar, and Nehra, Kuldeep
- Subjects
- *
THERAPEUTIC use of immunoglobulins , *COMBINATION drug therapy , *BACLOFEN , *THYROXINE , *IMMUNOSUPPRESSIVE agents , *DIAZEPAM , *IMMUNOGLOBULINS , *MYCOPHENOLIC acid , *AUTOANTIBODIES , *RITUXIMAB , *PREDNISOLONE , *ORAL drug administration , *TREATMENT effectiveness , *STIFF-person syndrome , *GABAPENTIN , *DISEASE relapse , *HYPOTHYROIDISM , *IMMUNOSUPPRESSION , *THERAPEUTICS - Abstract
Stiff-person syndrome (SPS) is a rare and complex neurologic disorder characterized by progressive muscle stiffness, painful spasms, and gait difficulties. In this report, we describe a case of SPS who presented with a relapse while on maintenance immunosuppressive treatment. In addition, we review the literature of 16 previously reported cases of SPS from India, highlighting the diverse clinical features, comorbidities, treatment response, and relapse. The occurrence of paraneoplastic SPS emphasizes the need for early recognition and diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.
- Author
-
Lott, Emma, Fehlings, Darcy, Gelineau-Morel, Rose, Kruer, Michael, Mink, Jonathan W., Thomas, Sruthi P., Wisniewski, Steve, and Aravamuthan, Bhooma
- Subjects
- *
DRUG dosage , *BACLOFEN , *HETEROCYCLIC compounds , *CANNABIDIOL , *DIAZEPAM , *RESEARCH funding , *PIPERIDINE , *METHYLDOPA , *CLONIDINE , *CEREBRAL palsy , *DESCRIPTIVE statistics , *DECISION making in clinical medicine , *SEVERITY of illness index , *FUNCTIONAL status , *PHYSICIANS' attitudes , *INJECTIONS , *SPASTICITY , *DYSTONIA , *PHYSICIAN practice patterns , *GABAPENTIN , *DRUG efficacy , *PAIN , *RETENTION of urine , *PHYSICIANS , *DRUG prescribing , *DRUGS , *CLONAZEPAM , *DRUG utilization , *DOPA , *CLOBAZAM , *CONSTIPATION , *DISEASE complications - Abstract
The article discusses research which investigated physician approaches to the pharmacologic dystonia treatment in people with cerebral palsy. The study surveyed physician approaches regarding medications for dystonia in CP including baclofen, trihexyphenidyl, gabapentin, carbidopa/levodopa, clonazepam, diazepam, clonidine, tetrabenazine, clobazam and cannabidiol. It described physician's prescribing practices and choice of medications for dystonia.
- Published
- 2024
- Full Text
- View/download PDF
39. Ameliorative Protective Influence of Etoricoxib Against Chemo Convulsions Correlates with Blood Glucose Levels in Rats.
- Author
-
Rajangam, Jayaraman, Palei, Narahari N., R., Prakash, Subramanam, Navaneetha Krishnan, P., Dharani Prasad, Ayyanna, Chakali, and Aparna, S.
- Subjects
BLOOD sugar ,SEIZURES (Medicine) ,BEHAVIORAL assessment ,DIAZEPAM ,NEUROTOXICOLOGY - Abstract
Objective: The effect of Etoricoxib (ETOR) on the link between blood glucose and seizure prevention in chemo-convulsive rats was investigated in this study. Methods: Pentylenetetrazol (PTZ-105 mg/kg i.p.) at the CD97 dosage was administered to rats to cause seizures. ETOR (10 mg/kg p.o.) was administered for two weeks prior to seizure induction. On the 14th day, the animals were exposed to chemo convulsions, and the efficiency of ETOR in lowering clonus-type chemo convulsions (CC) as well as blood glucose levels were assessed. Morphometric analysis and chimney tests were performed to evaluate ETOR's neurotoxic profile. Actophotometer, rotarod, and hole board tests were employed for behavioral analysis. Results: When compared to control mice, pretreatment with ETOR (10 mg/kg p.o) resulted in a substantial delay in the onset of CC (P<0.05) and duration of CC (P<0.01). Acute ETOR treatment also considerably lowered blood glucose levels. The chimney test findings show that it has no effect on motor control and is not neurotoxic to the animals. Conclusion: Behavioral tests also demonstrated that, except for the diazepam-treated groups, no significant changes in muscle coordination, locomotion, or apprehensive behavior were detected in all experimental animals. Finally, the primary findings of this study showed that the PTZ group had considerably greater levels of hyperglycemia, which is reflected in the rat's early onset and longer duration of chemo-convulsions. However, ETOR medication reduced high blood glucose levels as well as the onset and duration of seizures, indicating ETOR's impact on blood glucose reduction and the relationship between blood glucose and seizure responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Pharmacological evaluation of anxiolytic activity of ethanolic extract of Hemidesmus indicus in rodent model.
- Author
-
Malaiya, Saumya, Yadav, Shailja, Jain, Harshita, and Shrivastava, Arpit
- Subjects
AYURVEDIC medicine ,RODENTS ,DIAZEPAM ,ANXIETY ,DRUG standards - Abstract
The current study uses rodent models to explore the anxiolytic properties of Hemidesmus indicus' ethanolic extract (EEHI). Hemidesmus indicus, an evergreen plant well-known for its therapeutic characteristics, has been widely used in Ayurvedic medicine to treat a variety of conditions, including anxiety. This study seeks to give scientific validation for its anxiolytic properties. The ethanolic extract was made using normal extraction processes and given to rodents in varied doses (100,200 and 400 mg/kg). The anxiolytic activity was assessed using a variety of widely recognized behavioural assays, including the Elevated Plus Maze (EPM), Open Field Test (OFT), and Light-Dark Box (LDB) test. Diazepam (2 mg/kg) served as the standard reference drug. The results revealed that EEHI significantly reduced anxiety-like behaviours in all three tests when compared to the control group. In the EPM test, EEHI-treated rodents spent more time and entered the open arms. In the OFT, ambulation, rearing and assisted rearing increased, indicating lower levels of anxiety. The LDB test supported these findings, with a significant increase in time spent in the light compartment. The study suggests that EEHI has promising anxiolytic activity and may offer a natural treatment alternative for anxiety disorders. Further research is needed to isolate specific active molecules and better understand the underlying mechanisms of action. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Differential effects of allopregnanolone and diazepam on social behavior through modulation of neural oscillation dynamics in basolateral amygdala and medial prefrontal cortex.
- Author
-
Yosuke Yawata, Ryoichi Tashima, Hiroyuki Aritomi, Shinji Shimada, Tsukasa Onodera, Teruhiko Taishi, Keiko Takasu, and Koichi Ogawa
- Subjects
AMYGDALOID body ,SOCIAL defeat ,PREFRONTAL cortex ,PREGNANOLONE ,BENZODIAZEPINES ,DIAZEPAM ,SOCIAL interaction - Abstract
Effective treatments for major depressive disorder (MDD) have long been needed. One hypothesis for the mechanism of depression involves a decrease in neuroactive steroids such as allopregnanolone, an endogenous positive allosteric modulator of the γ-aminobutyric acid-gated chloride channel (GABAA) receptor. In our previous study, we discovered that allopregnanolone, not diazepam, exhibited antidepressant-like effects in the social interaction test (SIT) of social defeat stress (SDS) model mice. However, the dynamics of neuronal activity underlying the antidepressant-like effect remain unknown. In the current study, we conducted local field potentials (LFPs) recordings from the basolateral amygdala (BLA) and the medial prefrontal cortex (mPFC) during the SIT to elucidate the relationship between the antidepressant-like effect and neuronal oscillation. We discovered that allopregnanolone has antidepressantlike effects in the SIT of SDS model mice by decreasing intervals of repetitive social interaction (inter-event intervals), resulting in increase of total social interaction time. We also found that theta and beta oscillation increased in BLA at the onset of social interaction following administration of allopregnanolone, which differed from the effects of diazepam. Theta and beta power in BLA within the social interaction zone exhibited a positive correlation with interaction time. This increase of theta and beta power was negatively correlated with inter-event intervals. Regarding theta-band coordinated activity between the BLA and mPFC, theta power correlation decreased at the onset of social interaction with the administration of allopregnanolone. These findings suggest that theta activity in BLA following social interaction and the reduced theta-band coordinated activity between the BLA and mPFC are implicated in social interaction, which is one of the antidepressant behaviors. These differences in neural activity could elucidate the distinctive mechanism underlying antidepressant-like effects of neuroactive steroids, as opposed to benzodiazepines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Diazepam inhibits LPS-induced pyroptosis and inflammation and alleviates pulmonary fibrosis in mice by regulating the let-7a-5p/MYD88 axis.
- Author
-
Song, Duanyi, Tang, Xuefang, Du, Juan, Tao, Kang, and Li, Yun
- Subjects
- *
PULMONARY fibrosis , *DIAZEPAM , *PYROPTOSIS , *INFLAMMATION , *MICE - Abstract
Background and objective: Pulmonary fibrosis caused by lung injury is accompanied by varying degrees of inflammation, and diazepam can reduce the levels of inflammatory factors. Therefore, the purpose of this study was to determine whether diazepam can inhibit inflammation and ameliorate pulmonary fibrosis by regulating the let-7a-5p/myeloid differentiation factor 88 (MYD88) axis. Methods: Lipopolysaccharide (LPS) was used to induce cell pyroptosis in an animal model of pulmonary fibrosis. After treatment with diazepam, changes in cell proliferation and apoptosis were observed, and the occurrence of inflammation and pulmonary fibrosis in the mice was detected. Results: The results showed that LPS can successfully induce cell pyroptosis and inflammatory responses and cause lung fibrosis in mice. Diazepam inhibits the expression of pyroptosis-related factors and inflammatory factors; moreover, it attenuates the occurrence of pulmonary fibrosis in mice. Mechanistically, diazepam can upregulate the expression of let-7a-5p, inhibit the expression of MYD88, and reduce inflammation and inhibit pulmonary fibrosis by regulating the let-7a-5p/MYD88 axis. Conclusion: Our findings indicated that diazepam can inhibit LPS-induced pyroptosis and inflammatory responses and alleviate pulmonary fibrosis in mice by regulating the let-7a-5p/MYD88 axis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Clinical detoxification of bromazolam using diazepam: a case report.
- Author
-
Buitenhuis, Daan, Herdes, David P., and Verboeket, Sebastiaan O.
- Subjects
- *
DIAZEPAM , *DRUGS of abuse , *DRUG withdrawal symptoms , *BENZODIAZEPINES , *RESIDENTIAL care - Abstract
AbstractAn increasing number of new psychoactive substances (NPS), such as designer benzodiazepines, are becoming available on the recreational drug market. These are new unregistered substances and thereby an attempt to evade legislation. Often there is very limited clinical information available regarding these NPS, which could result in undesirable clinical outcomes in the management of intoxications, dependencies and withdrawals following NPS use. In this case report we describe a 23-year-old woman, who was admitted to our residential addiction care facility for the detoxification of the designer benzodiazepine bromazolam. Her daily use of 6 mg bromazolam was converted to 20 mg diazepam. Although we expected a higher dose would have been needed, 20 mg was sufficient and was tapered without complications. This case report demonstrates the safe conversion of 6 mg of bromazolam to 20 mg of diazepam by combining the use of fixed-dose and symptom-triggered-dose regimens. More clinical data is necessary to formulate advisory management for the detoxification of bromazolam and other designer benzodiazepines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Diazepam nasal spray administration is effective to control seizure clusters irrespective of time of day.
- Author
-
Liow, Kore, Wheless, James W., Cook, David F., Rabinowicz, Adrian L., and Carrazana, Enrique
- Subjects
INTRANASAL administration ,INTRANASAL medication ,DIAZEPAM ,SEIZURES (Medicine) ,ORAL medication - Abstract
Introduction: Neurologic circadian influences, including sleep/wake transitions, processes (e.g., hormonal variation), and behavioral patterns (e.g., consumption of food and oral medications), may affect seizure patterns. Specific circadian patterns of seizures have been reported depending on type, onset location, and severity; however, data on patterns for patients with seizure clusters and effectiveness of rescue therapy by time of day are limited. Methods: We conducted post hoc analyses using patient diary data from the phase 3 safety study of diazepam nasal spray, which is indicated for acute treatment of seizure clusters in patients with epilepsy aged =6 years. Patients were administered age- and weight-based doses; second doses could be administered if needed to control a seizure cluster. We assessed clock timing of seizure-cluster onset along with second-dose use as a proxy for effectiveness. Treatment-emergent adverse events were recorded. Results: Seizure-cluster onset was observed to be generally highest during mornings and late evenings and lowest in the early evening and middle of the night. Second-dose use was not consistently associated with a specific time of day. The safety profile was consistent with that expected from previous studies of diazepam nasal spray. Conclusion: These results suggest that diazepam nasal spray can be effectively administered at any time of day. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Gambaran Hematologi dari Pemberian Anestesi Kombinasi Ketamin-Xilazin dan Ketamin-Diazepam pada Pelaksanaan Kastrasi Anjing.
- Author
-
Utami, Tri, Tophianong, Tarsisius Considus, Semarabawa, I Gede, and Darang, Calvin Lummu
- Abstract
Carrying out castration on dogs requires anesthesia to prevent movement and relieve pain during the operation. The aim of this study was to evaluate the effects of administering two combinations of general anesthesia, ketamine-xylazine and ketamine-diazepam on haematological parameters for use in castration procedure in local breed of dogs. The dogs used in this study were six local breed of dogs and were randomly divided in two group with three dogs in each group. Blood sampling from the cephalic antebrachii vein of 1 ml was carried out twice, thirty minutes before surgery and sixty minutes after surgery. The average results of post-operative complete blood tests in dogs given ketamine (10 mg/kg body weight, iv)-xylazine (1 mg/kg body weight, iv) anesthesia, include: total erythrocyte count 5.84 x 10
6 /µL, haemoglobin 12.27 g/dL, haematocrit 36.7%, and leukocytes 15.4 x 10³ /µL. The average results of post-operative complete blood tests in dogs given ketamine (10 mg/kg body weight, iv)-diazepam (0.2 mg/kg body wight, iv) anesthesia, include: total erythrocyte count 5.98 x 106 /µL, haemoglobin 11.77 g/dL, haematocrit 36.23%, and leukocytes 16.4 x 10³ /µL. Based on the results of statistical analysis using the independent t-test, the number of total erythrocytes, haemoglobin, haematocrit and leukocytes post-operative between the two groups was not significantly different (P>0.05). The use of the combination of ketaminexylazine and ketamine-diazepam during castration did not cause changes in the number of total erythrocytes, haemoglobin, haematocrit and leukocytes. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
46. Effect of intramuscular diazepam infusion on herpes zoster-related pain in older patients: a randomized, double-blind, placebo-controlled trial.
- Author
-
Ma, Bingjie, Xu, Meiling, Yang, Lu, Huang, Xuehua, Wang, Peiliang, Ji, Yun, and Ma, Ke
- Subjects
- *
HERPES zoster , *NEURALGIA , *DIAZEPAM , *PLACEBOS , *PHYSIOLOGIC salines , *INTRAMUSCULAR injections , *STATISTICAL sampling , *BLIND experiment , *VISUAL analog scale , *QUESTIONNAIRES , *ANXIETY , *DESCRIPTIVE statistics , *PSYCHOLOGY , *PAIN , *PAIN management , *QUALITY of life , *SLEEP quality , *COMPARATIVE studies , *WELL-being , *MENTAL depression , *DISEASE complications , *OLD age - Abstract
Objectives: This study evaluated the effectiveness, psychological effects, and sleep quality using intramuscular diazepam infusion compared with placebo in patients with herpes zoster (HZ)-related pain. Methods: The patients were randomized to either the diazepam or control group. The diazepam group received an intramuscular injection of diazepam for 3 consecutive days, while the control group received an intramuscular injection of 0.9% normal saline. The primary outcome was pain relief on posttreatment day 4, as measured using the Visual Analog Scale (VAS). Moreover, anxiety and depression were evaluated using the Generalized Anxiety Disorder-7 (GAD7) and Patient Health Questionnaire-9 (PHQ9), respectively. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Results: In total, 78 patients were enrolled in the trial. The mean differences in VAS scores between the two groups were 0.62 (P = 0.049) on posttreatment day 3 and 0.66 (P = 0.037) on posttreatment day 4. The effective rates of pain management in the diazepam group ranged from 10.26 to 66.67%, which were higher than those in the control group on posttreatment days 3 and 4 (P < 0.05). The mean difference in PSQI scores between the diazepam and control groups was 1.36 (P = 0.034) on posttreatment day 7. No differences were found in the incidence of analgesia-adverse 1reactions between the diazepam and placebo groups. Conclusions: The intramuscular injection of diazepam for 3 consecutive days provides effective pain management and improves the quality of life. Our study suggests that diazepam is more effective than the placebo in patients with HZ-related pain. Trial registration: The study was prospectively registered at https://www.isrctn.com/trialist(Registration date: 24/01/2018; Trial ID: ISRCTN12682696). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Extrasynaptic δGABAA receptors mediate resistance to migraine-like phenotype in rats.
- Author
-
Alpay, Berkay, Cimen, Bariscan, Akaydin, Elif, Onat, Filiz, Bolay, Hayrunnisa, and Sara, Yildirim
- Subjects
- *
BACLOFEN , *HETEROCYCLIC compounds , *VISION disorders , *DIAZEPAM , *RESEARCH funding , *FLUMAZENIL , *NITROGLYCERIN , *RATS , *NERVOUS system , *ANIMAL experimentation , *BENZOPYRANS , *PHENOTYPES , *MIGRAINE , *CELL receptors , *ALLODYNIA , *ANTICONVULSANTS ,THERAPEUTIC use of nitroglycerin - Abstract
Background: GABA, a key inhibitory neurotransmitter, has synaptic and extrasynaptic receptors on the postsynaptic neuron. Background GABA, which spills over from the synaptic cleft, acts on extrasynaptic delta subunit containing GABAA receptors. The role of extrasynaptic GABAergic input in migraine is unknown. We investigated the susceptibility to valid migraine-provoking substances with clinically relevant behavioral readouts in Genetic Absence Epilepsy of Rats Strasbourg (GAERS), in which the GABAergic tonus was altered. Subsequently, we screened relevant GABAergic mechanisms in Wistar rats by pharmacological means to identify the mechanisms. Methods: Wistar and GAERS rats were administered nitroglycerin (10 mg/kg) or levcromakalim (1 mg/kg). Mechanical allodynia and photophobia were assessed using von Frey monofilaments and a dark-light box. Effects of GAT-1 blocker tiagabine (5 mg/kg), GABAB receptor agonist baclofen (2 mg/kg), synaptic GABAA receptor agonist diazepam (1 mg/kg), extrasynaptic GABAA receptor agonists gaboxadol (4 mg/kg), and muscimol (0.75 mg/kg), T-type calcium channel blocker ethosuximide (100 mg/kg) or synaptic GABAA receptor antagonist flumazenil (15 mg/kg) on levcromakalim-induced migraine phenotype were screened. Results: Unlike Wistar rats, GAERS exhibited no reduction in mechanical pain thresholds or light aversion following nitroglycerin or levcromakalim injection. Ethosuximide did not reverse the resistant phenotype in GAERS, excluding the role of T-type calcium channel dysfunction in this phenomenon. Tiagabine prevented levcromakalim-induced mechanical allodynia in Wistar rats, suggesting a key role in enhanced GABA spillover. Baclofen did not alleviate mechanical allodynia. Diazepam failed to mitigate levcromakalim-induced migraine phenotype. Additionally, the resistant phenotype in GAERS was not affected by flumazenil. Extrasynaptic GABAA receptor agonists gaboxadol and muscimol inhibited periorbital allodynia in Wistar rats. Conclusion: Our study introduced a rat strain resistant to migraine-provoking agents and signified a critical involvement of extrasynaptic δGABAergic receptors. Extrasynaptic δ GABAA receptors, by mediating constant background inhibition on the excitability of neurons, stand as a novel drug target with a therapeutic potential in migraine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Photodegradation of six selected antipsychiatric drugs; carbamazepine, sertraline, amisulpride, amitriptyline, diazepam, and alprazolam in environment: efficiency, pathway, and mechanism—a review.
- Author
-
Mohamadpour, Fahimeh and Mohamadpour, Farzaneh
- Abstract
Psychiatric drugs do not vanish after being carried to wastewater treatment plants by the urine or feces of patients and, a variable portion of their dose and also unused or expired drugs are lost to the environment. This is because the technology of plants is not intended to eradicate pharmaceuticals and their metabolites. Above all, psychotropics can change population dynamics and behavior at lower doses. We believe that antipsychotics have not gotten enough attention when it comes to drug pollution and that their importance as environmental pollutants has been underestimated. An innovative approach to eliminating pharmaceutical pollutants from water is the application of advanced oxidation methods. Among these oxidation methods are photocatalysis, ozonation, UV/hydrogen peroxide oxidation, and photo-Fenton oxidation. Photocatalytic degradation of pharmaceuticals is now the most widely used method since it is affordable and ecologically beneficial due to the reusable nature of the photocatalyst. When light is absorbed during photocatalytic degradation, electrons in the valence band (VB) get excited and migrate into the conduction band (CB). Consequently, hydroxyl radicals (
• OH) are produced by VB's holes carrying out oxidation processes on photocatalyst surfaces. The charge difference between the two bands encourages reduction reactions by CB electrons at the surface. To perform successfully, a photocatalyst has to have enough surface-active sites, a favorable band edge location, modest bandgap energy, increased charge separation, and charge transfer. Due to the above-mentioned concerns, the investigation and analysis of the photocatalytic degradation of six psychiatric drugs—carbamazepine, sertraline, amisulpride, amitriptyline, diazepam, and alprazolam—are the main objectives of this review. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
49. Knockdown of Tlr3 in dorsal striatum reduces ethanol consumption and acute functional tolerance in male mice.
- Author
-
Dilly, Geoffrey A., Blednov, Yuri A., Warden, Anna S., Ezerskiy, Lubov, Fleischer, Caleb, Plotkin, Jesse D., Patil, Shruti, Osterndorff-Kahanek, Elizabeth A., Mayfield, Jody, Mayfield, R. Dayne, Homanics, Gregg E., and Messing, Robert O.
- Subjects
- *
ETHANOL , *NUCLEUS accumbens , *DRINKING behavior , *GENOME editing , *LABORATORY mice - Abstract
• Tlr3 floxed (Tlr3F/F) mice were generated using CRISPR/Cas9 genome editing. • Cre recombination knocked down Tlr3 mainly in neurons. • Knockdown in dorsal striatum (DS) ↑ ataxia by ethanol and ↓ ethanol consumption. • Neuronal TLR3 signaling within the DS regulates ethanol drinking and intoxication. Systemic activation of toll-like receptor 3 (TLR3) signaling using poly(I:C), a TLR3 agonist, drives ethanol consumption in several rodent models, while global knockout of Tlr3 reduces drinking in C57BL/6J male mice. To determine if brain TLR3 pathways are involved in drinking behavior, we used CRISPR/Cas9 genome editing to generate a Tlr3 floxed (Tlr3F/F) mouse line. After sequence confirmation and functional validation of Tlr3 brain transcripts, we injected Tlr3F/F male mice with an adeno-associated virus expressing Cre recombinase (AAV5-CMV-Cre-GFP) to knockdown Tlr3 in the medial prefrontal cortex, nucleus accumbens, or dorsal striatum (DS). Only Tlr3 knockdown in the DS decreased two-bottle choice, every-other-day (2BC-EOD) ethanol consumption. DS-specific deletion of Tlr3 also increased intoxication and prevented acute functional tolerance to ethanol. In contrast, poly(I:C)-induced activation of TLR3 signaling decreased intoxication in male C57BL/6J mice, consistent with its ability to increase 2BC-EOD ethanol consumption in these mice. We also found that TLR3 was highly colocalized with DS neurons. AAV5-Cre transfection occurred predominantly in neurons, but there was minimal transfection in astrocytes and microglia. Collectively, our previous and current studies show that activating or inhibiting TLR3 signaling produces opposite effects on acute responses to ethanol and on ethanol consumption. While previous studies, however, used global knockout or systemic TLR3 activation (which alter peripheral and brain innate immune responses), the current results provide new evidence that brain TLR3 signaling regulates ethanol drinking. We propose that activation of TLR3 signaling in DS neurons increases ethanol consumption and that a striatal TLR3 pathway is a potential target to reduce excessive drinking. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Changing prescribing practice for rapid tranquillization–a quality improvement project based on the Plan-Do-Study-Act method.
- Author
-
Baandrup, Lone, Dons, Anne Mette, Bartholdy, Katja Vu, Holm, Katrine Overballe, and Hageman, Ida
- Subjects
- *
MENTAL health services , *MEDICAL care , *BENZODIAZEPINES , *TREND setters , *SAFETY standards , *PATIENT safety , *DIAZEPAM - Abstract
Purpose: It is unclear how the evidence from clinical trials best translates into complex clinical settings. The aim of this quality improvement (QI) project was to change prescribing practice for rapid tranquillization in inpatient mental health care services examining the effectiveness of the Plan-Do-Study-Act (PDSA) method. Methods: A prospective QI project was conducted to ensure that intramuscular (IM) diazepam was substituted with IM lorazepam for benzodiazepine rapid tranquillization in inpatient mental health care. We monitored the prescription and administration of medication for rapid tranquillization before (N = 371), during (N = 1130) and after (N = 364) the QI intervention. Seven iterative PDSA cycles with a multiple-component intervention approach were conducted to gradually turn the prescribing practice in the desired direction. Simultaneously, a standard monitoring regimen was introduced to ensure patient safety. Results: Lorazepam administrations gradually replaced diazepam during the intervention period which was sustained post-intervention where lorazepam comprised 96% of benzodiazepine administrations for rapid tranquillization. The mean dose of benzodiazepine administered remained stable from pre (14.40 mg diazepam equivalents) to post (14.61 mg) intervention phase. Close to full compliance (> 80%) with vital signs monitoring was achieved by the end of the observation period. Conclusion: It was possible to increase the quality of treatment of acute agitation in a large inpatient mental health care setting using a stepwise approach based on iterative PDSA cycles and continuous data feedback. This approach might be valuable in other prescribing practice scenarios with feedback from local stakeholders and opinion leaders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.